Momecutan Fettcreme (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momecutan Fettcreme, is a corticosteroid presented as a cream for topical use. It treats inflammatory skin conditions such as psoriasis, atopic dermatitis, contact dermatitis and lichen planus in patients as directed by a healthcare professional.

GNH USA supplies Momecutan Fettcreme as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU regulatory standards. The company ensures consistent quality and reliable delivery across global markets with comprehensive regulatory support and documentation.

Momecutan Fettcreme, a topical corticosteroid, is indicated for the management of several inflammatory skin disorders.

- Psoriasis: reduces scaling, erythema, plaque thickness and associated discomfort, improving skin appearance. - Atopic dermatitis: alleviates itching, redness, inflammation and skin barrier disruption, providing symptomatic relief. - Contact dermatitis: controls allergic skin reactions, diminishes redness and accelerates healing of affected areas. - Lichen planus: diminishes lesions, reduces itching and improves overall skin comfort.

Topical application of Momecutan Fettcreme may be associated with local adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Mild itching or irritation. - Skin dryness or flaking. - Folliculitis or acneiform eruptions. - Redness or mild erythema.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Development of striae (stretch marks). - Hypopigmentation or depigmentation of treated skin. - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression after extensive application. - Allergic contact dermatitis to the formulation.

Use of Momecutan Fettcreme requires careful consideration of patient‑specific factors. - Pregnancy: safety not established; prescribe only if potential benefit outweighs risk. - Breastfeeding: unknown excretion; consider risk versus benefit. - Application area: apply only to intact skin, avoiding eyes, mucous membranes and open wounds. - Duration: do not use over large body surface areas or for prolonged periods without medical supervision. - Occlusion: avoid covering treated skin with airtight dressings unless directed by a physician. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Topical corticosteroids can interact with other agents applied to the skin or absorbed systemically.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Topical antifungal agents (e.g., clotrimazole) on the same area: could alter absorption.

Moderate Interactions (Monitor Closely): - Phototherapy: may enhance skin irritation when combined. - Other topical immunosuppressants (e.g., tacrolimus): additive immunosuppressive effect. - Live vaccines: topical steroids may diminish local immune response, monitor vaccine efficacy.